Wayenberg L, Epelboin L, London J, Bricaire F, Caumes E
Service de maladies infectieuses et tropicales, groupe hospitalier Pitié-Salpêtrière, Paris, France.
Bull Soc Pathol Exot. 2013 Feb;106(1):1-4. doi: 10.1007/s13149-012-0268-3. Epub 2012 Nov 23.
The emergence of multi-resistant bacteria (MRB) in developing countries (DCs) is a worrying phenomenon at regional and international levels with a risk of international spread through travelers. The French guidelines recommend a systematic screening in case of hospitalization, for the travelers who have been repatriated and for those with a history of hospitalization in a foreign country during the past year. A simple travel in DCs is not considered as a risk factor for colonization or infection with a MRB. We report the case of a 56-year-old man with acute prostatitis and epididymitis due to Extended-spectrum β-lactamase-producing Escherichia coli. He was returning from Southeast Asia with no history of hospitalization or recent use of antibiotics. However, he had unprotected sex during his travel. This case report leads us to discuss the different ways of acquiring this resistant bacterium during travel as well as the usefulness of expanding the screening of carriage for MRB in all travelers in case of hospitalization.
发展中国家出现多重耐药菌在地区和国际层面都是一个令人担忧的现象，存在通过旅行者在国际上传播的风险。法国指南建议，对于住院患者、被遣返的旅行者以及过去一年内在国外有住院史的人，应进行系统筛查。在发展中国家进行的简单旅行不被视为感染多重耐药菌或被其定植的风险因素。我们报告一例56岁男性因产超广谱β-内酰胺酶的大肠埃希菌导致急性前列腺炎和附睾炎的病例。他从东南亚返回，无住院史且近期未使用过抗生素。然而，他在旅行期间有过无保护性行为。本病例报告促使我们讨论在旅行期间感染这种耐药菌的不同途径，以及在住院情况下扩大对所有旅行者进行多重耐药菌携带筛查的实用性。
